SHORT COURSE DURATION SOFOSBUVIR/VELPATASVIR IS INFERIOR TO STANDARD DURATION THERAPY IN THE TREATMENT OF RECENTLY ACQUIRED HCV INFECTION: RESULTS FROM REACT STUDYGail Matthews,Sanjay Bhagani,Marc Van der Valk,Juergen K. Rockstroh,Arthur Y. Kim,Christine Thurnheer,Jordan J. Feld,Julie Bruneau,Edward J. Gane,Margaret Hellard,Jason Grebely,Tanya Applegate,Pip Marks,Marianne Martinello,Kathy Petoumenos,Gregory DoreHEPATOLOGY（2019）引用 2|浏览26暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
